Will the Photobiomodulation Trial Be the One to Turn the Tide Against Alzheimer Disease

Michael R Hamblin

Related publications

Article2019

Photobiomodulation for Alzheimer’s Disease: Has the Light Dawned?

Michael R Hamblin

Article2020

Photobiomodulation for Alzheimer’s Disease: Translating Basic Research to Clinical Application

Joachim Enengl, Michael R Hamblin, Peter Dungel

Preprint2022

Evaluating prospective study registration and result reporting of trials conducted in Canada from 2009-2019

Mohsen Alayche, Kelly D. Cobey, Jeremy Y. Ng, Clare L. Ardern, Karim M. Khan, An‐Wen Chan, Ryan Chow, Mouayad Masalkhi, Ana Patricia Ayala, Sanam Ebrahimzadeh, Jason Ghossein, Ibrahim Alayche, Jessie V. Willis, David Moher

Article2012

Trial watch

Erika Vacchelli, Lorenzo Galluzzi, Wolf H. Fridman, Jérôme Galon, Catherine Sautès‐Fridman, Éric Tartour, Guido Guido Kroemer

Article2023

Evaluating prospective study registration and result reporting of trials conducted in Canada from 2009 to 2019

Mohsen Alayche, Kelly D. Cobey, Jeremy Y. Ng, Clare L. Ardern, Karim Khan, An‐Wen Chan, Ryan Chow, Mouayad Masalkhi, Ana Patricia Ayala, Sanam Ebrahimzadeh, Jason Ghossein, Ibrahim Alayche, Jessie V. Willis, David Moher